CLARITHROMYCIN-CIPROFLOXACIN-AMIKACIN FOR THERAPY OF MYCOBACTERIUM-AVIUM MYCOBACTERIUM-INTRACELLULARE BACTEREMIA IN PATIENTS WITH AIDS

被引：58

作者：

DELALLA, F ^{[1
]}

MASERATI, R ^{[1
]}

SCARPELLINI, P ^{[1
]}

MARONE, P ^{[1
]}

NICOLIN, R ^{[1
]}

CACCAMO, F ^{[1
]}

RIGOLI, R ^{[1
]}

机构：

[1] IST RIC & CURA CARATTERE SCI,DEPT INFECT DIS,PAVIA,ITALY

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1992年 / 36卷 / 07期

关键词：

D O I：

10.1128/AAC.36.7.1567

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A combination of clarithromycin, ciprofloxacin, and amikacin for the treatment of Mycobacterium avium-Mycobacterium intracellulare bacteremia was evaluated in 12 AIDS patients. Mycobacteremia cleared in all patients by 2 to 8 weeks of treatment, and symptoms resolved. Four patients died; all had negative blood cultures until death, add disseminated M. avium-M. intracellulare complex infection was not considered the primary cause of death.

引用

页码：1567 / 1569

页数：3

共 19 条

[1] COMPARATIVE INVITRO ACTIVITY OF THE NEW MACROLIDE A-56268 AGAINST MYCOBACTERIA
BERLIN, OGW
YOUNG, LS
FLOYDREISING, SA
BRUCKNER, DA
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) : 486 - 487
[2] ACTIVITY OF CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM INFECTION IN PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME - A CONTROLLED CLINICAL-TRIAL
DAUTZENBERG, B
TRUFFOT, C
LEGRIS, S
MEYOHAS, MC
BERLIE, HC
MERCAT, A
CHEVRET, S
GROSSET, J
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03): : 564 - 569
[3] DESFORGES JF, 1991, NEW ENGL J MED, V324, P1032
[4] INVITRO AND INVIVO ACTIVITIES OF CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM
FERNANDES, PB
HARDY, DJ
MCDANIEL, D
HANSON, CW
SWANSON, RN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) : 1531 - 1534
[5] INVITRO AND INVIVO EVALUATION OF A-56268 (TE-031), A NEW MACROLIDE
FERNANDES, PB
BAILER, R
SWANSON, R
HANSON, CW
MCDONALD, E
RAMER, N
HARDY, D
SHIPKOWITZ, N
BOWER, RR
GADE, E
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) : 865 - 873
[6] MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-INTRACELLULARE INFECTIONS IN PATIENTS WITH AND WITHOUT AIDS
GUTHERTZ, LS
DAMSKER, B
BOTTONE, EJ
FORD, EG
MIDURA, TF
JANDA, JM
[J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) : 1037 - 1041
[7] COMPARISON OF BACTERICIDAL ACTIVITIES OF STREPTOMYCIN, AMIKACIN, KANAMYCIN, AND CAPREOMYCIN AGAINST MYCOBACTERIUM-AVIUM AND M-TUBERCULOSIS
HEIFETS, L
LINDHOLMLEVY, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1298 - 1301
[8] QUADRUPLE-DRUG THERAPY FOR MYCOBACTERIUM-AVIUM-INTRACELLULARE BACTEREMIA IN AIDS PATIENTS
HOY, J
MIJCH, A
SANDLAND, M
GRAYSON, L
LUCAS, R
DWYER, B
[J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) : 801 - 805
[9] AMIKACIN, CIPROFLOXACIN, AND IMIPENEM TREATMENT FOR DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION OF BEIGE MICE
INDERLIED, CB
KOLONOSKI, PT
WU, M
YOUNG, LS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) : 176 - 180
[10] DETERMINATION OF INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM COMPLEX ISOLATES TO ANTIMYCOBACTERIAL AGENTS BY VARIOUS METHODS
INDERLIED, CB
YOUNG, LS
YAMADA, JK
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (11) : 1697 - 1702

← 1 2 →